PLK1 Is a Potential Prognostic Factor Associated with the Tumor Microenvironment in Lung Adenocarcinoma.

Abstract

More than 40% of lung cancers are lung adenocarcinoma (LUAD) worldwide. However, the prognosis of LUAD is poor for the lack of effective treatment methods. Our study identified PLK1 as a novel prognosis biomarker and treatment target for LUAD. Based on the Cancer Genome Atlas (TCGA) database, differentially expressed genes (DEGs) from 551 LUAD cases were analyzed for the Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. To explore the biological pathways and the tumor-infiltrating immune cells (TICs) using gene set variation analysis (GSVA) and the CIBERSORT, as well as to analyze DEGs, a protein-protein interaction (PPI) network and Cox regression analysis were performed. Validation of DEGs was achieved through quantitative real-time PCR (qPCR) and immunoblotting. DEGs associated with the cell cycle were sorted out. Cell cycle scores were positively correlated with age, clinical stages, and metastasis and negatively correlated with overall survival of LUAD patients. PPI and Cox analyses showed that PLK1 could be a prognostic factor for LUAD patients. CIBERSORT analysis revealed a positive correlation between the transcription level of PLK1 and the function of CD8+ and activated memory CD4+ T cells, as well as a negative correlation with activated natural killer cells. Furthermore, PLK1 overexpression increased immune cytotoxicity, as measured by the cytolytic activity score, IFN- score, and IFN- level. There is a strong correlation between PLK1 and key features of TICs, indicating its potential as a promising prognostic biomarker for LUAD.

• Authors: Lina Wang, Man Gao, Dongjie Sun, Haitao Wu, Shuang Lv, Yulin Li, Lisha Li
• Journal: BioMed research international (Biomed Res Int) Vol. 2022 Pg. 7848771 ( 2022) ISSN: 2314-6141 [Electronic] United States
• PMID: 35941968 (Publication Type: Journal Article, Retracted Publication)
• Copyright: Copyright © 2022 Lina Wang et al.

Chemical References

• Biomarkers, Tumor

Topics

• Adenocarcinoma of Lung (pathology)
• Biomarkers, Tumor (metabolism)
• Gene Expression Profiling (methods)
• Gene Expression Regulation, Neoplastic
• Humans
• Lung Neoplasms (pathology)
• Prognosis
• Tumor Microenvironment (genetics)